132 related articles for article (PubMed ID: 30815677)
1. MCAM abnormal expression and clinical outcome associations are highly cancer dependent as revealed through pan-cancer analysis.
An Y; Wei N; Cheng X; Li Y; Liu H; Wang J; Xu Z; Sun Z; Zhang X
Brief Bioinform; 2020 Mar; 21(2):709-718. PubMed ID: 30815677
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.
Zoni E; Astrologo L; Ng CKY; Piscuoglio S; Melsen J; Grosjean J; Klima I; Chen L; Snaar-Jagalska EB; Flanagan K; van der Pluijm G; Kloen P; Cecchini MG; Kruithof-de Julio M; Thalmann GN
Mol Cancer Res; 2019 May; 17(5):1049-1062. PubMed ID: 30745464
[TBL] [Abstract][Full Text] [Related]
3. MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation.
Liang YK; Zeng D; Xiao YS; Wu Y; Ouyang YX; Chen M; Li YC; Lin HY; Wei XL; Zhang YQ; Kruyt FA; Zhang GJ
Cancer Lett; 2017 Feb; 386():65-76. PubMed ID: 27838413
[TBL] [Abstract][Full Text] [Related]
4. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
[TBL] [Abstract][Full Text] [Related]
5. The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells.
von Burstin J; Bachhuber F; Paul M; Schmid RM; Rustgi AK
Mol Carcinog; 2017 Mar; 56(3):936-944. PubMed ID: 27583552
[TBL] [Abstract][Full Text] [Related]
6. Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.
Rapanotti MC; Suarez Viguria TM; Costanza G; Ricozzi I; Pierantozzi A; Di Stefani A; Campione E; Bernardini S; Chimenti S; Orlandi A; Bianchi L
Arch Dermatol Res; 2014 Aug; 306(6):527-37. PubMed ID: 24902661
[TBL] [Abstract][Full Text] [Related]
7. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells.
Colomb F; Wang W; Simpson D; Zafar M; Beynon R; Rhodes JM; Yu LG
J Biol Chem; 2017 May; 292(20):8381-8389. PubMed ID: 28364041
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer.
Liu JW; Nagpal JK; Jeronimo C; Lee JE; Henrique R; Kim MS; Ostrow KL; Yamashita K; van Criekinge V; Wu G; Moon CS; Trink B; Sidransky D
Prostate; 2008 Mar; 68(4):418-26. PubMed ID: 18196513
[TBL] [Abstract][Full Text] [Related]
10. MCAM and LAMA4 Are Highly Enriched in Tumor Blood Vessels of Renal Cell Carcinoma and Predict Patient Outcome.
Wragg JW; Finnity JP; Anderson JA; Ferguson HJ; Porfiri E; Bhatt RI; Murray PG; Heath VL; Bicknell R
Cancer Res; 2016 Apr; 76(8):2314-26. PubMed ID: 26921326
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
Wu GJ
Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
[TBL] [Abstract][Full Text] [Related]
12. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
13. Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness.
Chen Y; Sumardika IW; Tomonobu N; Kinoshita R; Inoue Y; Iioka H; Mitsui Y; Saito K; Ruma IMW; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Kubo M; Putranto EW; Murakami T; Liu M; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
Neoplasia; 2019 Jul; 21(7):627-640. PubMed ID: 31100639
[TBL] [Abstract][Full Text] [Related]
14. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor.
Guezguez B; Vigneron P; Lamerant N; Kieda C; Jaffredo T; Dunon D
J Immunol; 2007 Nov; 179(10):6673-85. PubMed ID: 17982057
[TBL] [Abstract][Full Text] [Related]
15. Identification of the elements regulating the expression of the cell adhesion molecule MCAM/MUC18. Loss of AP-2 is not required for MCAM expression in melanoma cell lines.
Mintz-Weber CS; Johnson JP
J Biol Chem; 2000 Nov; 275(44):34672-80. PubMed ID: 10938273
[TBL] [Abstract][Full Text] [Related]
16. Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma.
Bidlingmaier S; He J; Wang Y; An F; Feng J; Barbone D; Gao D; Franc B; Broaddus VC; Liu B
Cancer Res; 2009 Feb; 69(4):1570-7. PubMed ID: 19221091
[TBL] [Abstract][Full Text] [Related]
17. Beneficial roles of melanoma cell adhesion molecule in spinal cord transection recovery in adult zebrafish.
Liu CJ; Xie L; Cui C; Chu M; Zhao HD; Yao L; Li YH; Schachner M; Shen YQ
J Neurochem; 2016 Oct; 139(2):187-196. PubMed ID: 27318029
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Expression of MCAM/CD146 in Canine Melanoma.
Abou Asa S
J Comp Pathol; 2017 Jul; 157(1):27-33. PubMed ID: 28735667
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties.
Li X; Wang Y; Zhang Y; Liu B
Breast Cancer; 2022 Sep; 29(5):854-868. PubMed ID: 35553018
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumors.
Stalin J; Traboulsi W; Vivancos-Stalin L; Nollet M; Joshkon A; Bachelier R; Guillet B; Lacroix R; Foucault-Bertaud A; Leroyer AS; Dignat-George F; Bardin N; Blot-Chabaud M
Int J Cancer; 2020 Sep; 147(6):1666-1679. PubMed ID: 32022257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
